U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C17H13N3O2
Molecular Weight 291.304
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 2-(4-Methoxyphenyl)-2H-pyrazolo[4,3-c]quinolin-3-ol

SMILES

COC1=CC=C(C=C1)N2N=C3C(=CNC4=C3C=CC=C4)C2=O

InChI

InChIKey=KSKRJZMRHSNRBX-UHFFFAOYSA-N
InChI=1S/C17H13N3O2/c1-22-12-8-6-11(7-9-12)20-17(21)14-10-18-15-5-3-2-4-13(15)16(14)19-20/h2-10,18H,1H3

HIDE SMILES / InChI

Description
Curator's Comment: description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/27319298 | https://www.ncbi.nlm.nih.gov/pubmed/8388472 | https://google.com/patents/EP0022078B1 | https://www.ncbi.nlm.nih.gov/pubmed/3001268

CGS-9895 is nanomolar null modulator (antagonist) at the benzodiazepine binding site and at micromolar concentrations also modulate the receptors via the α+β- interface. The modulatory action of CGS 9895 is sensitive to the types of a and b subunit isoforms present in the receptor.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
0.1 nM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Benzodiazepine-induced hyperphagia: stereospecificity and antagonism by pyrazoloquinolines, CGS 9895 and CGS 9896.
1986
Patents

Patents

Sample Use Guides

Male CD1 mice were deprived of food for at least 2 h before oral administration of CGS-9895 (0.1, 0.3, 1, 3, 10, 30, 100 mg/kg). 1 h after drug treatment, mice were challenged with 60 mg/kg i.v. pentylenetetrazole. No antipentylenetetrazole activity of CGS 9895 could be detected at doses from 1-100 mg/kg.
Route of Administration: Oral
In Vitro Use Guide
The membranes from rat forebrains were prepared and washed. [35S]TBPS binding responses to varying concentrations of diazepam were measured in the presence or absence of 800 nM diazepam. Varying concentrations of CGS 9895 were coincubated with either the solvent or 800 nM diazepam. CGS 9895 increased [35S]TBPS binding in a concentration-dependent manner
Name Type Language
NSC-373970
Preferred Name English
2-(4-Methoxyphenyl)-2H-pyrazolo[4,3-c]quinolin-3-ol
Systematic Name English
3H-Pyrazolo[4,3-c]quinolin-3-one, 2,5-dihydro-2-(4-methoxyphenyl)-
Systematic Name English
2-(4-methoxyphenyl)-5H-pyrazolo[4,5-c]quinolin-3-one
Systematic Name English
2,5-Dihydro-2-(4-methoxyphenyl)-3H-pyrazolo[4,3-c]quinolin-3-one
Systematic Name English
2H-Pyrazolo[4,3-c]quinolin-3-ol, 2-(4-methoxyphenyl)-
Systematic Name English
CGS-9895
Common Name English
Code System Code Type Description
EPA CompTox
DTXSID80998971
Created by admin on Mon Mar 31 18:57:23 GMT 2025 , Edited by admin on Mon Mar 31 18:57:23 GMT 2025
PRIMARY
FDA UNII
VEN7HT4FPL
Created by admin on Mon Mar 31 18:57:23 GMT 2025 , Edited by admin on Mon Mar 31 18:57:23 GMT 2025
PRIMARY
NSC
373970
Created by admin on Mon Mar 31 18:57:23 GMT 2025 , Edited by admin on Mon Mar 31 18:57:23 GMT 2025
PRIMARY
CAS
77779-50-1
Created by admin on Mon Mar 31 18:57:23 GMT 2025 , Edited by admin on Mon Mar 31 18:57:23 GMT 2025
PRIMARY
PUBCHEM
100812
Created by admin on Mon Mar 31 18:57:23 GMT 2025 , Edited by admin on Mon Mar 31 18:57:23 GMT 2025
PRIMARY
CAS
2650307-15-4
Created by admin on Mon Mar 31 18:57:23 GMT 2025 , Edited by admin on Mon Mar 31 18:57:23 GMT 2025
ALTERNATIVE